3-(6-Bromo-1-oxoisoindolin-2-yl)piperidine-2,6-dione, 97%, 250mg

TERT-BUTYL 3-(2-AMINOPHENOXY)PIPERIDINE-1-CARBOXYLATE, 95.0%, 1g

Diisopropyl ether, min. 98%, for synthesis, stab., 2.5 l, glass packaging

3-Cyclobutene-1,2-dione, 3-[[(1S,2S)-2-aminocyclohexyl]amino]-4-[[3,5-bis(trifluoromethyl)phenyl]amino]-, 97%, 1g

(R)-1-Ethylpiperidin-3-amine dihydrochloride, 97%, 10g

2-hydroxyethyl methylcarbamate, 95.0%, 500mg

3-BROMO-2,6-DIMETHYLANILINE, 95.0%, 250mg

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-methylhexanoic acid, 95.0%, 100mg

4,6-BIS((S)-4-ISOPROPYL-4,5-DIHYDROOXAZOL-2-YL)DIBENZO[B,D]FURAN, 98%, 1g

tert-Butyl oxazol-5-ylcarbamate, 95.0%, 500mg

Ethyl 6-iodoimidazo[1,2-a]pyridine-2-carboxylate, 95.0%, 5g

3-Fluoroquinolin-5-amine, 95.0%, 5g

(6-Methoxynaphthalen-2-yl)methanol, 95%, 5g